Drug
Telotristat Ethyl
Telotristat Ethyl: highest development phase Phase 3, developed by Ipsen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Ipsen
Trials
| Drug | Phase | Indication |
|---|---|---|
| Telotristat Ethyl NCT04065165 | Phase 3 | Small Intestinal NET |
Latest
No recent events.
Follow Telotristat Ethyl on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.